Viking Global Performance Llc - Net Worth and Insider Trading
Viking Global Performance Llc Net Worth
The estimated net worth of Viking Global Performance Llc is at least $3.6 Billion dollars as of 2025-06-03. Viking Global Performance Llc is the 10% Owner of Myovant Sciences Ltd and owns about 40,765,599 shares of Myovant Sciences Ltd (MYOV) stock worth over $1.1 Billion. Viking Global Performance Llc is the 10% Owner of BridgeBio Pharma Inc and owns about 26,620,991 shares of BridgeBio Pharma Inc (BBIO) stock worth over $997 Million. Viking Global Performance Llc is also the 10% Owner of Roivant Sciences Ltd and owns about 75,238,700 shares of Roivant Sciences Ltd (ROIV) stock worth over $843 Million. Besides these, Viking Global Performance Llc also holds Urovant Sciences Ltd (UROV) , Adaptive Biotechnologies Corp (ADPT) , Sio Gene Therapies Inc (SIOX) . Details can be seen in Viking Global Performance Llc's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Viking Global Performance Llc has not made any transactions after 2023-06-22 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

Transaction Summary of Viking Global Performance Llc
Viking Global Performance Llc Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Viking Global Performance Llc owns 11 companies in total, including Adaptive Biotechnologies Corp (ADPT) , Arbutus Biopharma Corp (ABUS) , and Sio Gene Therapies Inc (SIOX) among others .
Click here to see the complete history of Viking Global Performance Llc’s form 4 insider trades.
Insider Ownership Summary of Viking Global Performance Llc
Ticker | Company | Transaction Date | Type of Owner |
---|---|---|---|
ADPT | Adaptive Biotechnologies Corp | 2020-11-11 | 10 percent owner |
ABUS | Arbutus Biopharma Corp | 2016-07-08 | 10 percent owner |
SIOX | Sio Gene Therapies Inc | 2019-03-18 | 10 percent owner |
![]() | ![]() | 2019-06-04 | 10 percent owner |
![]() | ![]() | 2019-07-10 | other: Former 10% Owner |
![]() | ![]() | 2019-06-27 | 10 percent owner |
![]() | ![]() | 2016-04-13 | 10 percent owner |
![]() | ![]() | 2016-02-08 | 10 percent owner |
![]() | ![]() | 2014-10-01 | 10 percent owner |
![]() | ![]() | 2023-06-22 | 10 percent owner |
![]() | ![]() | 2022-01-03 | 10 percent owner |
Viking Global Performance Llc Latest Holdings Summary
Viking Global Performance Llc currently owns a total of 6 stocks. Among these stocks, Viking Global Performance Llc owns 40,765,599 shares of Myovant Sciences Ltd (MYOV) as of June 4, 2019, with a value of $1.1 Billion and a weighting of 30.35%. Viking Global Performance Llc owns 26,620,991 shares of BridgeBio Pharma Inc (BBIO) as of June 27, 2019, with a value of $997 Million and a weighting of 27.51%. Viking Global Performance Llc also owns 75,238,700 shares of Roivant Sciences Ltd (ROIV) as of June 22, 2023, with a value of $843 Million and a weighting of 23.27%. The other 3 stocks Urovant Sciences Ltd (UROV) , Adaptive Biotechnologies Corp (ADPT) , Sio Gene Therapies Inc (SIOX) have a combined weighting of 18.87% among all his current holdings.
Latest Holdings of Viking Global Performance Llc
Ticker | Company | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
---|---|---|---|---|---|
MYOV | Myovant Sciences Ltd | 2019-06-04 | 40,765,599 | 26.98 | 1,099,855,861 |
BBIO | BridgeBio Pharma Inc | 2019-06-27 | 26,620,991 | 37.45 | 996,956,113 |
ROIV | Roivant Sciences Ltd | 2023-06-22 | 75,238,700 | 11.21 | 843,425,827 |
UROV | Urovant Sciences Ltd | 2019-06-19 | 22,860,013 | 16.24 | 371,246,611 |
ADPT | Adaptive Biotechnologies Corp | 2020-11-11 | 30,993,708 | 9.88 | 306,217,835 |
SIOX | Sio Gene Therapies Inc | 2019-03-18 | 13,244,048 | 0.48 | 6,330,655 |
Holding Weightings of Viking Global Performance Llc
Viking Global Performance Llc Form 4 Trading Tracker
According to the SEC Form 4 filings, Viking Global Performance Llc has made a total of 0 transactions in Myovant Sciences Ltd (MYOV) over the past 5 years. The most-recent trade in Myovant Sciences Ltd is the acquisition of 2,424,242 shares on June 4, 2019, which cost Viking Global Performance Llc around $20 Million.
According to the SEC Form 4 filings, Viking Global Performance Llc has made a total of 0 transactions in BridgeBio Pharma Inc (BBIO) over the past 5 years. The most-recent trade in BridgeBio Pharma Inc is the acquisition of 4,705,900 shares on June 27, 2019, which cost Viking Global Performance Llc around $80 Million.
According to the SEC Form 4 filings, Viking Global Performance Llc has made a total of 1 transactions in Roivant Sciences Ltd (ROIV) over the past 5 years, including 0 buys and 1 sells. The most-recent trade in Roivant Sciences Ltd is the sale of 13,000,000 shares on June 22, 2023, which brought Viking Global Performance Llc around $129 Million.
More details on Viking Global Performance Llc's insider transactions can be found in the Insider Trading History of Viking Global Performance Llc table.Insider Trading History of Viking Global Performance Llc
- 1
Viking Global Performance Llc Trading Performance
GuruFocus tracks the stock performance after each of Viking Global Performance Llc's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Viking Global Performance Llc is 1.57%. GuruFocus also compares Viking Global Performance Llc's trading performance to market benchmark return within the same time period. The performance of stocks bought by Viking Global Performance Llc within 3 months outperforms 9 times out of 16 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Viking Global Performance Llc's insider trading performs compared to the benchmark.
Performance of Viking Global Performance Llc
Viking Global Performance Llc Ownership Network
Ownership Network List of Viking Global Performance Llc
Ownership Network Relation of Viking Global Performance Llc

Viking Global Performance Llc Owned Company Details
What does Adaptive Biotechnologies Corp do?
Who are the key executives at Adaptive Biotechnologies Corp?
Viking Global Performance Llc is the 10 percent owner of Adaptive Biotechnologies Corp. Other key executives at Adaptive Biotechnologies Corp include Principal Accounting Officer Kyle Piskel , Chief Scientific Officer Harlan S Robins , and director & CEO and Chairman Chad M Robins .
Adaptive Biotechnologies Corp (ADPT) Insider Trades Summary
Over the past 18 months, Viking Global Performance Llc made no insider transaction in Adaptive Biotechnologies Corp (ADPT). Other recent insider transactions involving Adaptive Biotechnologies Corp (ADPT) include a net sale of 22,153 shares made by Kyle Piskel , a net sale of 1,023,797 shares made by Chad M Robins , and a net sale of 166,766 shares made by Harlan S Robins .
In summary, during the past 3 months, insiders sold 666,536 shares of Adaptive Biotechnologies Corp (ADPT) in total and bought 0 shares, with a net sale of 666,536 shares. During the past 18 months, 1,630,649 shares of Adaptive Biotechnologies Corp (ADPT) were sold and 0 shares were bought by its insiders, resulting in a net sale of 1,630,649 shares.
Adaptive Biotechnologies Corp (ADPT)'s detailed insider trading history can be found in Insider Trading Tracker table.
Adaptive Biotechnologies Corp Insider Transactions
Viking Global Performance Llc Mailing Address
Above is the net worth, insider trading, and ownership report for Viking Global Performance Llc. Based on the public information released on the U.S. Securities and Exchange Commission (SEC) website, Viking Global Performance Llc's mailing address is: Greenwich Ct 06830.